Project Grant H79SM091128

The Substance Abuse and Mental Health Services Administration awarded the Massachusetts Department of Mental Health $650,000 on September 30, 2026, under the Comprehensive Community Mental Health Services for Children with Serious Emotional Disturbances program (CFDA 93.104) to support the Massachusetts Psychosis Prevention Partnership (M3P).

M3P is a statewide initiative to identify youth and young adults at clinical high risk for psychosis and provide evidence-based stepped-care interventions to prevent or delay psychotic disorders. The program combines outreach and education, psychosis-risk screening via the PQ-B instrument, SIPS assessment, coordinated referral pathways, and trauma-informed, community-based, family-driven stepped-care services. Interventions include psychoeducation, cognitive-behavioral therapy for psychosis, acceptance and commitment therapy, family-focused treatment, substance use assessment and intervention, and academic and vocational support. Over the four-year performance period, M3P will screen 2,700 youth and provide comprehensive assessment and treatment services to 560 individuals across Massachusetts, particularly in rural areas. Seven CHR-P programs operate through integrated referral partnerships across healthcare, education, child welfare, and behavioral health systems, serving individuals up to age 25 experiencing attenuated psychotic symptoms, functional decline, and co-occurring conditions including anxiety, depression, trauma, and substance use.

Performance runs through September 29, 2030, with place of performance in Boston, Massachusetts.